Case Acceptance by Procedure: Which Treatments Your Patients Actually Say Yes To
Case Acceptance by Procedure: Which Treatments Your Patients Actually Say Yes To
Of the patients who actually sit in your chair, hear a diagnosis, and get handed a plan, 17% ignore the recommendation outright and another 29% delay it because of cost, according to the CareCredit/Synchrony Dental Lifetime of Care Study of 1,335 patients. That's not a marketing problem and it's not a demand problem. In a two-provider general practice presenting sixty units of major restorative a month, the ignored group alone is roughly $14,790 walking out the door every thirty days, and you already paid the rent, the assistant, and the hygiene department to generate it.
How patients respond to treatment recommendations
Source: CareCredit/Synchrony
Here's our view, and plenty of practice owners will argue with it: case acceptance by procedure is a vanity cut of the data. The per-code dashboards your consultant sells you, crown acceptance at 71%, implant acceptance at 38%, quadrant scaling and root planing at 54%, will not move a single dollar, because the procedure is not what the patient declined. The patient declined a dollar amount presented in a format they weren't ready for. Sort the same ledger by price band and by who did the talking, and the pattern that's actually costing you money shows up in about twenty minutes.
Orthodontists Sell the Priciest Case in Dentistry and Still Close 64.4%
Planet DDS analyzed 1,500 orthodontic practices and found average case acceptance of 64.4%, per the 2025 Dental Industry Outlook. Sit with that number for a second. Comprehensive orthodontic treatment is the largest single-case ticket most patients will ever be offered in a dental office. It's elective. It's usually cosmetic in the patient's mind, whatever the functional argument. Insurance covers a fraction of it at best, often capped for life at a couple thousand dollars. And roughly two out of three people say yes.
Now compare that to how a general practice loses a crown. The numbers aren't directly comparable, ortho practices measure acceptance off a consult that the patient scheduled specifically to discuss treatment, while a GP is often selling into an appointment the patient booked for a cleaning. That difference matters and we're not going to pretend it away. But it cuts in exactly the direction of our argument. The ortho practice wins the higher-priced case because the entire encounter is built around a decision. The GP loses the cheaper case because the decision got bolted onto the end of a hygiene visit by someone reading off a treatment plan printout.
Price is not the variable. If price were the variable, ortho would close at 20%.
What Most Owners Get Wrong: Treating the Code as the Objection
The specific mistake, and it's most common among owner-dentists who came up clinically strong and never worked a sales role in their life, is reading a low per-code acceptance number as clinical information. Implant acceptance is 38%, so implants must be a hard sell. Perio acceptance is soft, so patients must not believe in perio. That reasoning leads straight to the two useless responses we see over and over: buy better patient education software, or quietly stop diagnosing the category.
Both are wrong. The 38% isn't telling you patients dislike implants. It's telling you that a $4,800 recommendation delivered in the last four minutes of an appointment, by a doctor already running eleven minutes behind, with no financing conversation and no second touch, converts at 38%. Change any one of those inputs and the number moves without a single change to the clinical recommendation.
The second version of the same mistake is benchmarking against the practice next door. The 2025 Dental Economics-Levin Group Annual Practice Survey found 50% of practices cite patient financial and economic concerns as a top challenge to treatment. Half the market has the same complaint. A benchmark that half the field shares isn't a diagnosis, it's background noise. What matters is which of your own cases, in which dollar band, presented by which team member, in which appointment slot, died.
Ten Ignored Crowns a Month Is $177,480 a Year
Run it on a real practice. Two providers, $1.4 million in collections, sixty units of major restorative presented per month at an average net collectible of $1,450. That's $87,000 in monthly presented treatment on that band alone.
Apply the CareCredit study's 17% outright-ignore rate and you lose about ten cases a month, or $14,790.
Annualize it and you're looking at $177,480 in treatment you diagnosed, documented, and never produced.
That figure is worth holding next to the Bureau of Labor Statistics median annual wage for dentists of $176,110 as of May 2025. The treatment your practice diagnosed and lost in a year is worth slightly more than a full-time dentist's median pay. You are, in effect, employing a phantom associate who produces nothing.
The delay group is worse than it looks. At 29%, that's another 17.4 cases a month, roughly $25,230 in deferred production.
Assume half of those patients never actually come back for it within eighteen months, which is generous in most practices. That's another $12,615 a month, or $151,380 a year, that your production reports are quietly counting as "pending."
Now the part owners skip. At 62% overhead on $1.4 million, your operating cost is $868,000 a year.
Two providers at 30 clinical hours a week across 46 working weeks gives you 2,760 doctor chair hours.
That's $314.49 of fixed cost per chair hour, and it does not go down when a patient declines.
A crown that never gets seated still burned its 1.5 hours of capacity in diagnosis, presentation, and the follow-up nobody made, and that capacity carried $471.74 of overhead with it.
Here's the swing. You don't need ortho's 64.4%. Recover five of those ten ignored cases a month and you add $7,250 in monthly production.
That's $87,000 a year, from patients already in your chairs, with no new marketing spend, in a market where ADA Health Policy Institute data shows only 45% of the U.S. population had a dental visit in the past twelve months. National dental expenditures hit $189 billion in 2024. The money is in the room already.
Cut the Ledger by Dollar Band, Not by CDT Code
Pull your last ninety days of unscheduled treatment and sort it three ways. First, by out-of-pocket dollar band: under $500, $500 to $1,500, $1,500 to $4,000, above $4,000. Second, by who presented it, the doctor, the hygienist, or the treatment coordinator. Third, by whether the patient left with a financing option in hand or left with a total.
You'll almost certainly find that acceptance is smooth and predictable below a threshold, then falls off a cliff at one specific number, usually somewhere between $900 and $1,800 of patient out-of-pocket. That cliff is your actual constraint. It has nothing to do with whether the procedure was a crown, a build-up, an onlay, or a quadrant of perio therapy. Those codes just happen to cluster on either side of the line.
Our call: stop reporting acceptance by code at your monthly meeting. Report it by band and by presenter. The per-code view tells you what you already know, that expensive things are harder to sell. The band-and-presenter view tells you which specific conversation, in which specific room, is leaking money.
Financing Presented Last Is Financing Presented Wrong
The Dental Economics-Levin Group survey found 17.5% of practices reported increased use of third-party financing in 2025. Good. Most of them are still deploying it as a rescue move, which is why it underperforms.
The sequence in most general practices runs: present the clinical need, present the total, absorb the flinch, then offer financing as damage control. The patient has already heard the number and already decided. Financing introduced at that point reads as a concession, and patients treat concessions as evidence that the price was soft to begin with.
Orthodontic practices have never done it that way. The monthly figure and the down payment are the offer. The total is supporting detail. We'd restructure the presentation on anything above your cliff number to lead with the monthly, and we wouldn't take the argument that this is somehow less transparent. Presenting a $4,800 implant case as a total, watching the patient decline, and then charting it as "patient not interested" is the less honest version.
Where the Per-Procedure View Still Earns Its Keep
We'll grant one exception, because it's real. Per-procedure tracking is genuinely useful where the gap is diagnostic visibility rather than price. Perio is the clearest case. A patient can see a fractured cusp on an intraoral photo. They cannot see 5mm pockets without you showing them, and a probing depth chart is not a picture. If your perio acceptance is soft at a dollar band where your restorative acceptance is fine, that's not a money objection and no financing structure will fix it. That's a belief problem, and it gets solved with photography, comparison, and a second visit.
So the honest version of our position isn't that procedure-level data is worthless. It's that owners run it as their primary cut when it should be a secondary one, used to catch the handful of categories where the patient genuinely doesn't believe the diagnosis. Everything else is a price-band problem wearing a CDT code.
What Would Change Our Mind
Two things. If per-procedure acceptance gaps held steady across dollar bands, meaning implants underperformed crowns even at matched patient out-of-pocket, that would be real evidence that procedure type drives the decision independent of price, and we'd revise. We haven't seen a dataset that tests it cleanly, and we're watching for one.
The second is financing saturation. If third-party financing adoption keeps climbing past the 17.5% growth figure and acceptance in the $1,500-plus band doesn't move with it, the constraint is somewhere else, most likely in patient trust or in the appointment structure itself. We'll be tracking whether the next round of practice survey data shows financing uptake and high-band acceptance moving together or apart. If they diverge, the entire "present the monthly" playbook needs rewriting, ours included.
Four Moves Before Friday
Pull ninety days of unscheduled treatment and sort it by patient out-of-pocket band instead of by code, then find the dollar figure where acceptance falls off. Tag every one of those cases with who presented it and whether a monthly payment number was spoken out loud before the total was. Pick the single band above your cliff and change nothing except the sequence, monthly first, total second, for thirty days. Then compare, because if you change four things at once you'll learn nothing.
Patients don't decline crowns. They decline sentences that end in a number they weren't prepared to hear, and the sentence is the only part of that you control.
Before you change the presentation, know what an empty chair actually costs you. Our overhead calculator gives you your real fixed cost per chair hour, the $314-ish figure in the scenario above, so you can price the cost of every declined case instead of guessing at it. Run your own numbers and see what your version of that $177,480 looks like.